ArticleClinical cancer research : an official journal of the American Association for Cancer Research2017

Efficacy of Anti-mesothelin Immunotoxin RG7787 plus Nab-Paclitaxel against Mesothelioma Patient-Derived Xenografts and Mesothelin as a Biomarker of Tumor Response.

Jingli Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.